Stocktoria
AVANOS MEDICAL, INC. AVNS
NYSE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2014-10-21 · LEI
AVANOS MEDICAL, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $701.2M | $687.8M | $673.3M | $684.1M | $587.0M | $714.8M | $697.6M | $652.3M | $611.6M | $566.2M |
| Gross profit | $353.9M | $381.3M | $379.7M | $394.2M | $299.2M | $370.9M | $402.2M | $390.9M | $336.9M | $297.2M |
| R&D expense | $23.3M | $26.2M | $27.2M | $29.2M | $30.6M | $34.9M | $37.7M | $41.8M | $38.2M | $38.4M |
| SG&A expense | $315.6M | $318.5M | $335.0M | $326.5M | $285.3M | $332.6M | $399.1M | $340.4M | $321.7M | $346.2M |
| Operating income | -$61.6M | -$396.2M | $4.2M | $35.5M | -$39.0M | -$48.5M | -$55.7M | $500,000 | -$43.1M | -$107.1M |
| Interest expense | — | — | $15.0M | $10.0M | $3.3M | $15.6M | $15.0M | $26.4M | $31.6M | $32.7M |
| Income tax | $6.7M | -$17.0M | $2.0M | $5.2M | -$11.2M | -$33.9M | -$18.1M | -$9.6M | -$40.1M | -$55.9M |
| Net income | -$72.9M | -$392.1M | -$61.8M | $50.5M | $6.3M | -$29.0M | -$45.9M | $57.5M | $79.3M | $39.8M |
| EPS (diluted) | $-1.57 | $-8.53 | $-1.32 | $1.07 | $0.13 | $-0.61 | $-0.96 | $1.22 | $1.69 | $0.85 |
| Operating cash flow | $74.7M | $100.7M | $32.4M | $90.9M | $87.3M | -$2.5M | -$74.5M | -$145.6M | $144.2M | $188.8M |
| Cash & equivalents | $89.8M | $107.7M | $87.7M | $127.7M | $118.5M | $111.5M | $205.3M | $384.5M | $219.7M | $113.7M |
| Inventory | $148.0M | $138.8M | $163.2M | $132.3M | $159.3M | $168.9M | $145.9M | $121.4M | $91.1M | $80.7M |
| Total assets | $1.1B | $1.2B | $1.7B | $1.8B | $1.6B | $1.7B | $1.8B | $1.8B | $2.2B | $2.1B |
| Total liabilities | $295.5M | $325.7M | $456.1M | $495.7M | $333.0M | $416.3M | $534.4M | $536.2M | $980.5M | $969.3M |
| Shareholders' equity | $778.2M | $828.5M | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.1B |
Growth · year-over-year · Revenue CAGR 2.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +1.9% | +2.2% | -1.6% | +16.5% | -17.9% | +2.5% | +6.9% | +6.7% | +8.0% | +11.2% |
| Net income growth | — | — | -222.4% | +701.6% | — | — | -179.8% | -27.5% | +99.2% | — |
| EPS growth | — | — | -223.4% | +723.1% | — | — | -178.7% | -27.8% | +98.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.